Over the next few weeks, Emergent will add two senior leaders to its Quality and Compliance and Contract Development & Manufacturing (CDMO) organizations. 

 

Starting April 1, Coleen Glessner will join Emergent as Executive Vice President with enterprise responsibility for the Global Quality and Ethics and Compliance functions reporting directly to the CEO, Robert Kramer. Glessner comes to Emergent from Alexion Pharmaceuticals where she was Senior Vice President and Chief Quality Officer.

 

Bill Hartzel is joining Emergent as Senior Vice President for CDMO starting March 14. Hartzel will lead Emergent’s CDMO business, reporting to Chief Operating Officer Adam Havey. Hartzel was most recently Chief Commercial Officer for Woodstock Sterile Solutions. 

 

“Rigorous quality and compliance practices and the growth of our CDMO business are critical to Emergent’s future success, and I am pleased we have been able to add two experienced and accomplished leaders like Coleen and Bill,” said Emergent CEO Robert G. Kramer. “I also want to thank the individuals who stepped up in interim roles to provide operational continuity and who are ensuring a smooth transition between leaders while continuing to deliver for our patients, customers, and shareholders.”